ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,816
Screening encounters
4,484
Diagnostic referrals
853
Outstanding pathways
308

Screening pathway

  1. Screening4,484Encounters
  2. Positive finding1,547Documented findings
  3. Referral853Diagnostic referrals
  4. Follow-up1,012Diagnostic visits
  5. Outcome545Resolved pathways

Stage totals use different units. Pending pathways: 308. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 1908 · EXP-1908Synthetic · Site D

Full participant history through 2026-11-12, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-03-22
  4. · Screening · HPV DNA · Repeat · Prior HPV positive
  5. · Screening result · HPV DNA · HPV detected · Adequate
  6. · Diagnostic referral · EXP-1908-T-R
  7. · Contact attempt · Unsuccessful
  8. · Diagnostic booking · Initial booking
  9. · Contact attempt · Reached
  10. · Diagnostic visit · Attended
  11. · Diagnosis · Colposcopy · Biopsy collected
  12. · Diagnosis · Histopathology · No high-grade lesion identified
  13. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-05-19
  14. · Follow-up disposition · Resolved · EXP-1908-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3816 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-1754 · Expanded synthetic participant 1754Site B — Peri-Urban Access Programme
EXP-1755 · Expanded synthetic participant 1755Site E — Resource-Constrained Navigation Programme
EXP-1756 · Expanded synthetic participant 1756Site C — Rural Outreach Programme
EXP-1757 · Expanded synthetic participant 1757Site D — Community Engagement Programme
EXP-1758 · Expanded synthetic participant 1758Site B — Peri-Urban Access Programme
EXP-1759 · Expanded synthetic participant 1759Site C — Rural Outreach Programme
EXP-1761 · Expanded synthetic participant 1761Site E — Resource-Constrained Navigation Programme
EXP-1762 · Expanded synthetic participant 1762Site C — Rural Outreach Programme
EXP-1763 · Expanded synthetic participant 1763Site A — Urban Referral Hub
EXP-1764 · Expanded synthetic participant 1764Site A — Urban Referral Hub
EXP-1765 · Expanded synthetic participant 1765Site A — Urban Referral Hub
EXP-1768 · Expanded synthetic participant 1768Site A — Urban Referral Hub
EXP-1770 · Expanded synthetic participant 1770Site C — Rural Outreach Programme
EXP-1771 · Expanded synthetic participant 1771Site B — Peri-Urban Access Programme
EXP-1773 · Expanded synthetic participant 1773Site B — Peri-Urban Access Programme
EXP-1774 · Expanded synthetic participant 1774Site D — Community Engagement Programme
EXP-1775 · Expanded synthetic participant 1775Site B — Peri-Urban Access Programme
EXP-1777 · Expanded synthetic participant 1777Site D — Community Engagement Programme
EXP-1778 · Expanded synthetic participant 1778Site B — Peri-Urban Access Programme
EXP-1780 · Expanded synthetic participant 1780Site C — Rural Outreach Programme
EXP-1781 · Expanded synthetic participant 1781Site B — Peri-Urban Access Programme
EXP-1785 · Expanded synthetic participant 1785Site D — Community Engagement Programme
EXP-1786 · Expanded synthetic participant 1786Site D — Community Engagement Programme
EXP-1789 · Expanded synthetic participant 1789Site E — Resource-Constrained Navigation Programme
EXP-1791 · Expanded synthetic participant 1791Site B — Peri-Urban Access Programme

Programme insights

Encounters by modality

VIA
1722
HPV DNA
2132
Cytology
630

Navigation activity

Barrier documented
760
Contact attempt
1255
Navigation intervention
326
Diagnostic booking
1064
Diagnostic visit
1012

Documented barriers

Contact difficulty
246
Transport difficulty
250
Appointment coordination
264

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.